Are the neuroprotective effects mediated by G-CSF-responsive brain cells or circulating (marrow-derived) cells?

Dr. Dietrich shares his research which explores structural and functional brain repair mechanisms after cancer therapy induced nervous system injury.

Dr. Dietrich reports the following consulting fees or paid advisory boards for the past two years: Monteris Medical Corporation, Unum Therapeutics, and Blue Earth Diagnostics.

Dr. Dietrich reports the following current grant support, including non-profit/government entitites: Amy Gallagher Foundation 2017-2019, NIH R21 2018-2020, NIH R01 2018-2022.